News
December 7, 2022
Investor
Summary of Consolidated Financial Results for the Three Months Ended October 31, 2022 (Based on Japanese GAAP) 
December 6, 2022
Investor
COMPANY RESEARCH AND ANALYSIS REPORT(FISCO)
September 7, 2022
Investor
Summary of Consolidated Financial Results for the Year Ended July 31, 2022 (Based on Japanese GAAP)
June 6, 2022
Investor
Company Research And Analysis Report（FISCO）
June 6, 2022
Investor
Summary of Consolidated Financial Results for the Nine Months Ended April 30, 2022 (Based on Japanese GAAP)
April 8, 2022
Media
NHK WORLD-JAPAN「Reusing Eggshells to Create New Materials」
March 10, 2022
Investor
Summary of Consolidated Financial Results for the Six Months Ended January 31, 2022 (Based on Japanese GAAP)
January 21, 2022
Research and Development
Towards the Expansion of Cognitive Health Market in North America.Health Canada Recognizes Functional Properties of PharmaGABA
December 6, 2022
Investor
COMPANY RESEARCH AND ANALYSIS REPORT(FISCO)
September 7, 2022
Investor
Summary of Consolidated Financial Results for the Year Ended July 31, 2022 (Based on Japanese GAAP)
June 6, 2022
Investor
Company Research And Analysis Report（FISCO）
June 6, 2022
Investor
Summary of Consolidated Financial Results for the Nine Months Ended April 30, 2022 (Based on Japanese GAAP)
April 8, 2022
Media
NHK WORLD-JAPAN「Reusing Eggshells to Create New Materials」
March 10, 2022
Investor
Summary of Consolidated Financial Results for the Six Months Ended January 31, 2022 (Based on Japanese GAAP)
January 21, 2022
Research and Development
Towards the Expansion of Cognitive Health Market in North America.Health Canada Recognizes Functional Properties of PharmaGABA